Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2119 participants.

Also called NCT01443104

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,119 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01443104
Main results
  • Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial Lancet (London, England), 2014-12-13 DOI, PubMed 25189359
Other papers using this trial's data
  • Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-12-10 DOI, PubMed 26690319
  • Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial Circulation. Cardiovascular interventions, 2015-06 DOI, PubMed 26043895
  • Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial Cardiovascular revascularization medicine : including molecular interventions, 2022-01 DOI, PubMed 33653633
  • Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents Journal of the American Heart Association, 2019-11-19 DOI, PubMed 31696762, PMC6915288 In the PMC Open Access subset under CC BY-NC-ND.
  • Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Circulation. Cardiovascular interventions, 2019-08 DOI, PubMed 31525083
  • Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial Journal of the American Heart Association, 2016-03-15 DOI, PubMed 26979080, PMC4943287 In the PMC Open Access subset under CC BY-NC-ND.
  • Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial Lancet (London, England), 2018-09-01 DOI, PubMed 30170848

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01443104. Randomized; no masking; primary purpose treatment. Start 2012-02 (actual); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Condition
Angina Pectoris
Intervention (Device)
Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)
Intervention (Device)
Everolimus-eluting stent with a durable polymer
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
Biotronik AG (class: industry)
Collaborator
University of Bern (class: other)

Record details

Record id
cardio:ct-nct01443104
Content hash
25319ae6ac114863e99a4759860f15aa967cf1c99ff846d64157bf008ffcf47a